drugset / Trial / NCT00323687
SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada
Non-randomizedSingle-groupOpen-labelTreatment
Summary
There is an unmet medical need for potent ART regimens that make adherence to treatment even easier due to QD dosing, offer a good tolerability profile and fit into the daily life of patients.
Timeline
- Start
- 2004-09
- Primary completion
- 2006-10
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir | Small molecule | 200 mg | Oral |
| Subject | Tenofovir | Small molecule | 300 mg | Oral |